3,4-methylenedioxyamphetamine has been researched along with proadifen in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
DiStefano, V; Ling, LL; Marquardt, GM | 1 |
Brewster, WK; Johnson, MP; Nichols, DE; Steele, TD; Yim, GK | 1 |
Ali, SF; Gollamudi, R; Kolta, M; Leakey, JE; Lipe, G; Lopez, M; Newport, G; Slikker, W; Webb, P | 1 |
Colado, MI; Green, AR; Williams, JL | 1 |
4 other study(ies) available for 3,4-methylenedioxyamphetamine and proadifen
Article | Year |
---|---|
Pharmacological and toxicological effects of beta-3,4-methylenedioxyamphetamine isomers.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Behavior, Animal; Blood Pressure; Cats; Female; Hallucinogens; Isomerism; Lysergic Acid Diethylamide; Male; Mescaline; Mice; Proadifen | 1978 |
Assessment of the role of alpha-methylepinine in the neurotoxicity of MDMA.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Biogenic Amines; Brain Chemistry; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Deoxyepinephrine; Electrochemistry; Injections, Intraventricular; Male; Mice; Microsomes, Liver; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Phenobarbital; Proadifen; Rats; Rats, Inbred Strains; Species Specificity | 1991 |
Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Biotransformation; Brain Chemistry; Cerebral Cortex; Dealkylation; Female; In Vitro Techniques; Male; Mass Spectrometry; Microsomes, Liver; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Agents; Phenobarbital; Proadifen; Proteins; Rats; Rats, Inbred Strains; Serotonin; Stereoisomerism | 1989 |
The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Body Temperature Regulation; Brain; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Female; Fever; Humans; Hydroxyindoleacetic Acid; Male; Mixed Function Oxygenases; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Phenotype; Proadifen; Quinidine; Rats; Rectum; Serotonin; Serotonin Agents; Sex Factors; Tritium | 1995 |